`
`Application Number:
`
`17642795
`
`International Application Number:
`
`PCT/EP2020/075541
`
`Confirmation Number:
`
`4404
`
`
`
`a
`
`Title of Invention:
`
`LASSAVIRUS VACCINES
`
`re
`
`Paymentinformation:
`
`37 CFR 1.19 (Document supply fees)
`
`Authorized User
`
`Sarah Wilson
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpaymentas follows:
`
`37 CFR 1.17 (Patent application and reexamination processing fees)
`
`
`
`37 CFR 1.20 (Post Issuance fees)
`
`37 CFR 1.21 (Miscellaneous fees and charges)
`
`37 CFR 1.492 (National application filing, search, and examination fees)
`
`File Listing:
`
`Pages
`Multi
`File Size(Bytes)/
`DocumentDescription
`Document
`
`
`
`Number Message Digest|Part/.zip|P (if appl.)
`358574
`
`Transmittal of New Application
`
`2022-03-14_Transmittal_Letter
`“KATOO6OPApdf
`
`b1b86c381b17724e11faSb87d927b562b9
`91d071
`
`Information:
`
`2
`
`Application Data Sheet
`
`2022003-14ADKATOOCOPA.
`p
`
`3fa92e6192d8270dfff6ca34d654d502f8d8
`dSa
`
`1256246
`
`Information:
`
`Information:
`
`Information:
`
`Drawings-only black and white line
`drawings
`
`2022-03-14_PreliminaryAmdtN
`PE_KATOO60PA.pdf
`
`93ef4d2fadfad541e4b72619e2e27860a2eal
`
`Multipart Description/PDF files in .zip description
`
`Preliminary Amendment
`
`Specification
`
`Claims
`
`Drawings-only black and white line drawings
`
`Applicant Arguments/Remarks Made in an Amendment
`
`1241508
`
`2022-03-14_ReplacementDrawi
`ngs_KATOO60PA.pdf
`
`4fb97a067a6b32f9e1f361ae291 bfcficdbb9
`9c6
`
`
`
`Information:
`
`Information:
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`d8961a30dd9c131d9ac6bf28c355101d735}
`a433a
`
`This AcknowledgementReceipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable.It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`.
`.
`Oath or Declarationfiled
`
`2022-03-14 _Declarations_KATO
`_!
`|
`O60PA.pdf
`
`333304
`
`49645065f5f8c5d95c1 e205396955d91 3b5
`3c8dd
`
`2
`
`2
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary componentsfora filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownonthis
`AcknowledgementReceiptwill establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903indicating acceptanceof the application as a
`national stage submission under35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shownon this AcknowledgementReceiptwill establish the international filing date of
`
`